Inhibrx Biosciences Inc

INBXNASDAQ · USD
100.33USD-10.34 (-9.35%)
1310

Inhibrx Biosciences Inc (INBX) Implied Volatility Current

INBX implied volatility is 88%. IV Rank is 19%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking INBX implied volatility helps you identify when options premiums on Inhibrx Biosciences Inc are historically cheap or expensive, and where the best trades are hiding. Inhibrx Biosciences Inc implied volatility reflects the market's expectation of future price movement: when INBX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Inhibrx Biosciences Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For INBX, tracking metrics like INBX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on INBX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma.

The company was incorporated in 2024 and is based in La Jolla, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where INBX implied volatility sits today versus where it has been. Our scanner ranks Inhibrx Biosciences Inc implied volatility against its historical range, surfaces extremes in INBX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Inhibrx Biosciences Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
19.44%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)87.78%

IV Rank19.44%

Historical Volatility (30d)71.90%

IV - HV+15.88%

As of September 22, 2026

Trade options with IV on your side

Track INBX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial